Analysts’ new coverage for Wednesday, January 28th:Barclays PLC initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY). Barclays PLC issued an overweight rating and a $527.00 target price on the stock. Barclays PLC issued an overweight rating on the stock. Barclays PLC issued an overweight rating and a $95.00 price target on the stock. Barclays PLC issued an overweight rating and a $191.00 target price on the stock.